Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?

Management of metastatic radioiodine refractory differentiated thyroid cancer (DTC) can be a therapeutic challenge. Generally, little is known about the paired molecular profile of the primary tumor and the metastases and whether they harbor the same genetic abnormalities. The present study compared...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Endocrinol (Lausanne)
Autors principals: Gomes-Lima, Cristiane J., Shobab, Leila, Wu, Di, Ylli, Dorina, Bikas, Athanasios, McCoy, Matthew, Feldman, Rebecca, Lee, Wen, Rao, Sarika N., Jensen, Kirk, Vasko, Vasily, Castro, Luiz Claudio, Jonklaas, Jacqueline, Wartofsky, Leonard, Burman, Kenneth D.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7949910/
https://ncbi.nlm.nih.gov/pubmed/33716974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.623182
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars